StockWatch
·

Research Reports

05 Aug 2026
ASTERDMAster DM Healthcare Ltd

Aster DM Quality Care Q1: PAT crashes on ₹114cr merger cost; EBITDA still +27.5% YoY

hospital chain · healthcare · merger integration

ResultsQ1 FY273 minPharma & Healthcare
BIOCONBIOCON LTD.

Biocon Q1FY27: Consolidated PAT Up 53% YoY to ₹137 Cr as BBL Becomes Wholly Owned

biosimilars growth · margin expansion · crdmo headwinds

ResultsQ1 FY273 minPharma & Healthcare
NEULANDLABNEULAND LABORATORIES LTD.

Neuland Q1 FY27: consolidated PAT jumps 6x YoY to ₹147.7 Cr, margins cool from Q4 peak

api cdmo · sterile apis · margin normalization

ResultsQ1 FY273 minPharma & Healthcare
SHILPAMEDSHILPA MEDICARE LTD.

Shilpa Medicare Q1 FY27: PAT ₹101 Cr, +115% YoY but adjusted growth ~61% ex tax boost

deferred tax reversal · margin expansion · biologics cdmo

ResultsQ1 FY273 minPharma & Healthcare
FREDUNFredun Pharmaceuticals Ltd

Fredun Pharma Q1FY27: consolidated PAT +94% YoY to ₹13.1 Cr, revenue nearly doubles, margins expand

pharmaceuticals · consolidated results · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
METROPOLISMetropolis Healthcare Ltd

Metropolis Q1FY27: consol PAT +25.7% YoY to ₹56.9 Cr, margin gain meets FY27 guide

diagnostics · pathology services · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
04 Aug 2026
NOVARTINDNOVARTIS INDIA LTD.

Novartis India: When Global Pharma Steps Back

promoter exit · private equity acquisition · ChrysCapital

ResearchDeep dive5 minPharma & Healthcare
MOREPENLABMOREPEN LABORATORIES LTD.

Morepen Labs consolidated PAT surges 425% YoY to ₹56.4 Cr on record revenue, margins triple

pharma · cdmo · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
APLLTDALEMBIC PHARMACEUTICALS LTD.

Alembic Q1FY27 revenue up 26% YoY beats guidance; US ramp drags consol PAT growth to 12%

us generics ramp · margin compression · revenue beat

ResultsQ1 FY273 minPharma & Healthcare
AGARWALEYEDr. Agarwals Health Care Ltd

Dr Agarwal's Q1 PAT up 44.6% YoY to ₹55 Cr as margins expand, revenue grows 26%

eye care · hospital chain · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
NOVARTINDNOVARTIS INDIA LTD.

Novartis Steps Back: A ₹1,376 Crore Strategic Exit from India

Acquisition · Private Equity · Pharma

ResearchDeep dive6 minPharma & Healthcare
POLYMEDPOLY MEDICURE LTD.

Credibility quarter: Can new management establish execution amid ambitious FY27 growth?

Result previewQ1 FY273 minPharma & Healthcare
COHANCESuven Pharmaceuticals Ltd

New CEO's First Print: Can Umang Vohra Stabilize API Plus While Scaling Specialty?

Result previewQ1 FY273 minPharma & Healthcare
APLLTDALEMBIC PHARMACEUTICALS LTD.

US specialty ramp under way—watch ANDA momentum & margin durability

specialty generics · ANDA approvals · oncology pivot

Result previewQ1 FY273 minPharma & Healthcare
AGARWALEYEDr. Agarwals Health Care Ltd

Strong growth, integration questions — Q1 sets FY27 tone amid Agarwal's Eye Hospital merger

margin sustainability · merger integration · facility expansion

Result previewQ1 FY273 minPharma & Healthcare
GLANDGland Pharma Ltd

Post-Q4 euphoria: Can Gland sustain momentum with Sugammadex on the board?

generic pharma · USFDA approval · Sugammadex launch

Result previewQ1 FY273 minPharma & Healthcare
FORTISFORTIS HEALTHCARE LTD.

Hospital margin expansion on track; watch diagnostics for pivot to double-digit growth

hospital margins · diagnostics growth · capacity expansion

Result previewQ1 FY273 minPharma & Healthcare
03 Aug 2026
KIMSKrishna Institute of Medical Sciences Ltd

KIMS Q1FY27: consolidated PAT down 56% YoY on expansion costs, revenue up 35%

hospitals · healthcare · margin compression

ResultsQ1 FY273 minPharma & Healthcare
DRAGARWQDR.AGARWALS EYE HOSPITAL LTD.-$

Standalone PAT up 35% YoY to ₹23.4 Cr on 33% lower finance costs; revenue +22%

eye care · hospital chain · net margin expansion

ResultsQ1 FY273 minPharma & Healthcare
ARTEMISMEDArtemis Medicare Services Ltd

Artemis Medicare Q1 FY27: consolidated PAT +48% YoY on margin expansion to 19.6% OPM

hospitals · healthcare services · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
GPTHEALTHGPT Healthcare Ltd

GPT Healthcare Q1FY27: standalone PAT +65.7% YoY on margin expansion, revenue up 17.8%

hospitals · healthcare services · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
KAYAKaya Ltd

Kaya Q1 FY27: standalone loss widens 8% YoY to ₹15.2 Cr despite 14% revenue growth

skin care · hair care · standalone loss

ResultsQ1 FY273 minPharma & Healthcare
PARKHOSPSPark Medi World Ltd

Park Medi World Q1: consolidated PAT ₹88.6 Cr up 35% YoY as new hospitals scale

hospitals · healthcare services · bed capacity expansion

ResultsQ1 FY273 minPharma & Healthcare
ASTERDMAster DM Healthcare Ltd

First quarter of merged healthcare giant: focus on integration execution and synergy ramp

healthcare · merger · integration

Result previewQ1 FY273 minPharma & Healthcare
SAILIFESai Life Sciences Ltd

Q1 FY27: Capex Drag & Margin Pressure — What to Expect From India's CDMO Champion

CDMO · capex · EBITDA margins

Result previewQ1 FY273 minPharma & Healthcare
EMCUREEmcure Pharmaceuticals Ltd

Margin Play on Biologics — Emcure Q1 FY27 in Focus

biosimilars · margin expansion · Gennova

Result previewQ1 FY273 minPharma & Healthcare
LUPINLUPIN LTD.

Growth off a modest base, catalyzed by US product momentum

revenue growth · US FDA approvals · margin trajectory

Result previewQ1 FY273 minPharma & Healthcare
02 Aug 2026
SANOFISanofi India Ltd

Diabetes Momentum Under Spotlight as Sanofi India Reports Q1

diabetes growth · insulin portfolio · margins

Result previewQ1 FY273 minPharma & Healthcare
GLAXOGLAXOSMITHKLINE PHARMACEUTICALS LTD.

GSK India's Specialty Pivot: Can Q1 Sustain the FY27 Double-Digit Promise?

oncology · specialty medicines · vaccines

Result previewQ1 FY273 minPharma & Healthcare
BIOCONBIOCON LTD.

Recovery Test: Can BIOCON Restore Margins After Q3 Loss?

margin recovery · BBL consolidation · biosimilar momentum

Result previewQ1 FY273 minPharma & Healthcare